[Evolution of medical practice in the care of @entity417 amd the use of XXXX in chronic renal insufficiency hemodialysis in the past six years].

@entity1 @entity1307 @entity417 @entity6
In order to analyze changes in @entity417 management in the hemodialysis @entity1 , a retrospective survey was performed in 1999 on a representative French sample of @entity1 in hemodialysis treated by @entity1307 since 1992, 1994, 1996, and 1998 respectively. 368 @entity1 were enrolled in 97 centres. At treatment initiation, some @entity1 characteristics have significantly changed: the percentage of type 2 @entity6 @entity1 has increased marquedly from 4.5% in 1992 to 22.1% in 1998. The mean time lag between dialysis and @entity1307 treatment initiation has decreased from 3.3 years to 0.9 on the 6-year period. Lastly, the mean hemoglobin level has increased from 73.7 to 78.5 g/l. No significant evolution in the @entity1307 protocol was observed at the initiation as well as in the maintenance phase. An average percentage of 33.7% of @entity1 were treated in i.v. route at initiation with a mean posology of 105.2 IU/kg (respectively 91.4 in s.c.). In the first year of follow-up, the overall mean posology was 84 IU/kg. In conclusion, this survey suggests that @entity417 management has been optimized over the last 6 years follow-up, including an earlier initiation of @entity1307 treatment and a higher target of hemoglobin while @entity1307 needs were reduced in the same time.
